Foundation model 4

AI-powered image editing model with semantic, appearance, and text editing. Qwen-Image-Edit is a revolutionary 20B parameter AI image editing foundation model released by Alibaba's Qwen team. Built on the Qwen-Image generative model, it extends unique text rendering capabilities to image editing, enabling precise editing of Chinese and English text. The model features high-level semantic editing and appearance editing capabilities, offering a comprehensive solution that significantly lowers the barriers to image content creation and modification. It is open-source under the Apache 2.0 license.

Aesthetic-driven AI image generator with advanced style transfer and creative control. Krea 2 AI is a foundation image model built from the ground up for aesthetic diversity and creative control. It enables users to generate visuals through text-to-image prompts or transform reference images using an advanced style transfer system. Designed for artists, designers, and studios, it offers high-resolution output (1K-2K) and allows for precise visual direction, including multi-reference style blending, without the common 'safe' or 'polished' AI look found in other models.

AI text-guided video editing for character and scene transformation. Lucy Edit by Decart is the first foundation model for text-guided video editing. It allows users to seamlessly edit videos by changing outfits, adding accessories, or transforming characters, all guided by a simple text prompt. The model ensures that motion, face, and identity are perfectly preserved while the scene adapts around them. It is available in two versions: Dev, an open-weight community model, and Pro, a more consistent, detailed, and reliable version for creators seeking sharper results. Both versions support 480p and 720p editing and are accessible via API, platform, Hugging Face, and ComfyUI.

Variational AI uses generative AI for drug discovery, partnering with biopharmaceutical companies. Variational AI is a company that uses advanced generative AI for drug discovery. They collaborate with biopharmaceutical partners to develop new therapeutics across various disease areas, aiming to positively impact lives. Their Enki™ Platform is a commercially accessible foundation model for small molecules, trained on a vast amount of experimental data. They focus on creating novel and selective lead structures quickly, without requiring initial data, by defining the Target Product Profile (TPP).